$KOAN
Resonate Blends Inc Stock $koan

$koan Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224014876 Filed on April 16, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$656.2K	$0.00	$16.47K
YoY Change	10216.43%	-100.0%	-66.73%
Cost Of Revenue	$266.7K	$100.9K	$114.1K
YoY Change	5593.02%	1150.06%	245.15%
Gross Profit	$389.5K	-$100.9K	-$97.67K
YoY Change	23140.45%	-19880.39%	-694.46%
Gross Profit Margin	59.36%		-593.02%
Selling, General & Admin	$607.3K	$105.9K	$301.6K
YoY Change	1108.98%	-55.85%	-78.43%
% of Gross Profit	155.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$15.25K	$2.270K	$8.810K
YoY Change	686.08%	84.55%	13.82%
% of Gross Profit	3.92%
Operating Expenses	$1.098M	$105.9K	$301.6K
YoY Change	2086.18%	-56.07%	-78.55%
Operating Profit	-$708.6K	-$206.8K	-$399.2K
YoY Change	1359.44%	-14.05%	-71.27%
Interest Expense		-$314.6K	-$851.0K
YoY Change		449.92%	-141.24%
% of Operating Profit
Other Income/Expense, Net		$116.9K	-$160.7K
YoY Change		1053.8%	642.06%
Pretax Income	-$708.6K	-$404.6K	-$1.416M
YoY Change	76.14%	266.94%	-316.63%
Income Tax
% Of Pretax Income
Net Earnings	-$708.6K	-$404.6K	-$1.416M
YoY Change	76.14%	266.94%	-316.63%
Net Earnings / Revenue	-107.99%		-8597.33%
Basic Earnings Per Share	-$0.01		-$0.02
Diluted Earnings Per Share	-$0.01	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	96.18M shares	86.62M shares	80.01M shares
Diluted Shares Outstanding			80.01M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.13K	$6.940K	$6.940K
YoY Change	657.96%	-89.23%	-89.23%
Cash & Equivalents	$17.03K	$6.938K
Short-Term Investments	$100.00
Other Short-Term Assets	$970.0K	$970.0K	$970.0K
YoY Change	122.99%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$993.1K	$976.9K	$976.9K
YoY Change	50.87%	160.58%	160.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.30K	$15.30K	$15.30K
YoY Change	-20.18%	-36.54%	-36.54%
Goodwill
YoY Change
Intangibles	$0.00	$0.00
YoY Change
Long-Term Investments	$691.6K	$100.00	$100.00
YoY Change	691482.0%	0.0%	0.0%
Other Assets	$691.6K
YoY Change
Total Long-Term Assets	$706.9K	$15.40K	$15.40K
YoY Change	3567.94%	-36.39%	-36.39%
TOTAL ASSETS
Total Short-Term Assets	$993.1K	$976.9K	$976.9K
Total Long-Term Assets	$706.9K	$15.40K	$15.40K
Total Assets	$1.700M	$992.3K	$992.3K
YoY Change	150.91%	148.63%	148.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$917.4K	$445.2K	$445.2K
YoY Change	207.44%	39.3%	39.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$3.133M	$2.446M	$2.446M
YoY Change	57.93%	147.34%	147.34%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.051M	$3.128M	$3.128M
YoY Change	45.88%	102.34%	102.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.051M	$3.128M	$3.128M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.051M	$3.128M	$3.128M
YoY Change	45.88%	102.34%	102.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.99M	-$26.74M
YoY Change	7.21%	5.59%
Common Stock	$9.618K	$8.662K
YoY Change	22.79%	14.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.351M	-$2.136M	-$2.136M
YoY Change
Total Liabilities & Shareholders Equity	$1.700M	$992.3K	$992.3K
YoY Change	150.91%	148.63%	148.63%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$708.6K	-$404.6K	-$1.416M
YoY Change	76.14%	266.94%	-316.63%
Depreciation, Depletion And Amortization	$15.25K	$2.270K	$8.810K
YoY Change	686.08%	84.55%	13.82%
Cash From Operating Activities	-$236.4K	-$78.65K	$11.17K
YoY Change	721.44%	-262.57%	-100.78%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$486.9K	-$85.00K	-$805.0K
YoY Change	11.94%
Cash From Investing Activities	-$486.9K	-$85.00K	-$805.0K
YoY Change	11.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$30.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	675.2K	170.0K	736.4K
YoY Change	45.21%	-165.69%	-50.25%
NET CHANGE
Cash From Operating Activities	-236.4K	-78.65K	11.17K
Cash From Investing Activities	-486.9K	-85.00K	-805.0K
Cash From Financing Activities	675.2K	170.0K	736.4K
Net Change In Cash	-48.10K	6.350K	-57.48K
YoY Change	-4042.62%	-103.02%	-211.61%
FREE CASH FLOW
Cash From Operating Activities	-$236.4K	-$78.65K	$11.17K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases		usd
CY2022Q4	us-gaap	Senior Notes Current SeniorNotesCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	KOAN	Non Cash Expenses Management Fees NonCashExpensesManagementFees		usd
CY2022	KOAN	Gain Loss On Settlement Of Notes Payable GainLossOnSettlementOfNotesPayable		usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	KOAN	Non Cash Interest Expense NonCashInterestExpense		usd
CY2022	KOAN	Loss On Settlement Of Notes Payable LossOnSettlementOfNotesPayable		usd
CY2023	KOAN	Stock Subscription Receivable StockSubscriptionReceivable		usd
CY2022	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments		usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	KOAN	Proceeds From Subscription ProceedsFromSubscription		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6732534	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	96179058	shares
CY2023	dei	Auditor Name AuditorName	Victor Mokuolu, CPA PLLC
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023	dei	Auditor Firm AuditorFirmId	6771
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6938	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64419	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	160492	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	150000	usd
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	970000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	976938	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	374911	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15303	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24110	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	100	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	100	usd
CY2023Q4	us-gaap	Assets Assets	992341	usd
CY2022Q4	us-gaap	Assets Assets	399121	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	445219	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	319618	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1845734	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	988800	usd
CY2023Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	600000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	166861	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	72487	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3127913	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1545851	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3127913	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1545851	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86623596	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86623596	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75437604	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75437604	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8662	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7544	usd
CY2023Q4	KOAN	Stocks Subscription Receivable StocksSubscriptionReceivable	-261059	usd
CY2022Q4	KOAN	Stocks Subscription Receivable StocksSubscriptionReceivable	-261059	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24853028	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24427009	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26736403	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25320424	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2135572	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1146730	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	992341	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	399121	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16468	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49501	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	114140	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	33068	usd
CY2023	us-gaap	Gross Profit GrossProfit	-97672	usd
CY2022	us-gaap	Gross Profit GrossProfit	16433	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	23772	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	378706	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	163903	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	210057	usd
CY2023	KOAN	Legal And Professional Fees LegalAndProfessionalFees	85126	usd
CY2022	KOAN	Legal And Professional Fees LegalAndProfessionalFees	176478	usd
CY2023	us-gaap	Officers Compensation OfficersCompensation	28750	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	434125	usd
CY2022	KOAN	Non Cash Expenses Management Fees NonCashExpensesManagementFees	206462	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	301551	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-399223	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	636616	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-94374	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	160733	usd
CY2023	KOAN	Gain Loss On Settlement Of Notes Payable GainLossOnSettlementOfNotesPayable	-5033	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-120000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	11355	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1016756	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2043022	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1415979	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	653627	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80013557	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80013557	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4101931	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	243917	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1846607	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	211050	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	653627	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1146730	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1146730	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-247142	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1273273	shares
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2303	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	382077	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7671	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	242228	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1415979	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1415979	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2135572	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1415979	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	653627	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-94374	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2213527	usd
CY2023	KOAN	Non Cash Interest Expense NonCashInterestExpense	160733	usd
CY2023	KOAN	Loss On Settlement Of Notes Payable LossOnSettlementOfNotesPayable	5033	usd
CY2023	KOAN	Share Professional Fees Compensation ShareProfessionalFeesCompensation	392051	usd
CY2022	KOAN	Share Professional Fees Compensation ShareProfessionalFeesCompensation	206462	usd
CY2023	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	8807	usd
CY2022	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	7738	usd
CY2022	KOAN	Stock Subscription Receivable StockSubscriptionReceivable	-261059	usd
CY2023	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	120000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-160492	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-85283	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-10830	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-30000	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	150000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	455655	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	112233	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	119946	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11166	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1428467	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	805000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-805000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	930000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1388800	usd
CY2022	KOAN	Proceeds From Subscription ProceedsFromSubscription	91173	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	94847	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	138800	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	736353	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1479973	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-57481	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	51506	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	64419	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12913	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6938	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	64419	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	242228	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	2265000	usd
CY2013Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	The Company also voted to approve a 1 for 5 reverse split of its outstanding common stock.
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26736403	usd
CY2023Q4	KOAN	Working Capital WorkingCapital	2150975	usd
CY2022Q4	KOAN	Working Capital WorkingCapital	1170940	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1415979	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	653627	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zp3TBBejurjb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zzOOBriaZbr6">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	166861	usd
CY2022Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	72487	usd
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	100883	usd
CY2023	KOAN	Property And Equipment Excess Capitalized Cost PropertyAndEquipmentExcessCapitalizedCost	1000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	23772	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	378706	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.0133
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.030
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	4.60	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.20	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0464	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0145	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y1M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	420000	shares
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1852500	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	988800	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6766	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1845734	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	988800	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	453125	usd
CY2019Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	the Company signed a lease agreement that expires on thirty days’ notice.
CY2023	us-gaap	Payments For Rent PaymentsForRent	5912	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	10591	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26000000	usd
CY2023	KOAN	Operating Loss Carryforwards Expirations Date OperatingLossCarryforwardsExpirationsDate	expire beginning in the year 2030
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5460764	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5376927	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5460764	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5376927	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30000	usd

Files In Submission

Name	View Source	Status
0001493152-24-014876-index-headers.html	Edgar Link	pending
0001493152-24-014876-index.html	Edgar Link	pending
0001493152-24-014876.txt	Edgar Link	pending
0001493152-24-014876-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
koan-20231231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
koan-20231231_def.xml	Edgar Link	unprocessable
koan-20231231_lab.xml	Edgar Link	unprocessable
koan-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
koan-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KOAN
Resonate Blends Inc Stock $koan

2024 Q2 Form 10-K Financial Statement

#000149315224014876 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOAN Resonate Blends Inc Stock $koan

2024 Q2 Form 10-K Financial Statement

#000149315224014876 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOAN
Resonate Blends Inc Stock $koan